This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Werner Meier
Chief Scientific Officer at Revitope Oncology


Revitope Oncology: Chief Scientific Officer and acting CEO Biogen: Vice President of Biologics Drug Discovery, responsible for developing therapeutic protein drug candidates. Program Executive of two development programs aimed at treating immunologic and neurological diseases Applied BioMath and Institute for Protein Innovation: Scientific board member

Agenda Sessions

  • Progress on REV403, A Guided Antibody T cell Engager Targeting EGFR and PDL1 for Solid Tumors